WoodTrust Financial Corp lessened its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 8.0% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 15,214 shares of the healthcare conglomerate’s stock after selling 1,326 shares during the period. UnitedHealth Group makes up approximately 1.4% of WoodTrust Financial Corp’s portfolio, making the stock its 27th largest position. WoodTrust Financial Corp’s holdings in UnitedHealth Group were worth $3,306,000 at the end of the most recent quarter.
A number of other hedge funds have also recently added to or reduced their stakes in the stock. City Holding Co. grew its position in UnitedHealth Group by 28.5% during the third quarter. City Holding Co. now owns 676 shares of the healthcare conglomerate’s stock valued at $147,000 after buying an additional 150 shares during the period. Exane Derivatives acquired a new stake in UnitedHealth Group during the third quarter valued at $632,000. Triangle Securities Wealth Management grew its position in UnitedHealth Group by 4.2% during the third quarter. Triangle Securities Wealth Management now owns 6,068 shares of the healthcare conglomerate’s stock valued at $1,319,000 after buying an additional 242 shares during the period. Ferguson Wellman Capital Management Inc. grew its position in UnitedHealth Group by 38.5% during the third quarter. Ferguson Wellman Capital Management Inc. now owns 123,329 shares of the healthcare conglomerate’s stock valued at $26,802,000 after buying an additional 34,306 shares during the period. Finally, Bristol John W & Co. Inc. NY grew its position in UnitedHealth Group by 2.2% during the third quarter. Bristol John W & Co. Inc. NY now owns 347,046 shares of the healthcare conglomerate’s stock valued at $75,420,000 after buying an additional 7,382 shares during the period. Institutional investors own 85.71% of the company’s stock.
UNH traded up $18.00 during midday trading on Tuesday, hitting $238.59. 13,444,584 shares of the company traded hands, compared to its average volume of 4,604,256. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.62. The company has a market capitalization of $210.45 billion, a price-to-earnings ratio of 18.52, a PEG ratio of 1.18 and a beta of 0.60. UnitedHealth Group Inc has a 52-week low of $208.07 and a 52-week high of $287.94. The business has a 50 day simple moving average of $226.54 and a two-hundred day simple moving average of $239.74.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $3.88 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $3.75 by $0.13. The business had revenue of $60.35 billion for the quarter, compared to the consensus estimate of $59.84 billion. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The company’s revenue was up 6.7% compared to the same quarter last year. During the same period last year, the firm posted $3.41 earnings per share. Equities research analysts anticipate that UnitedHealth Group Inc will post 14.83 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a $1.08 dividend. This represents a $4.32 annualized dividend and a dividend yield of 1.81%. The ex-dividend date of this dividend was Friday, September 13th. UnitedHealth Group’s dividend payout ratio is currently 33.54%.
UNH has been the topic of several analyst reports. Royal Bank of Canada set a $311.00 price target on shares of UnitedHealth Group and gave the company a “buy” rating in a research report on Friday, July 19th. Deutsche Bank began coverage on shares of UnitedHealth Group in a research report on Thursday, September 12th. They set a “hold” rating and a $263.00 price target on the stock. Jefferies Financial Group downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating and decreased their price objective for the company from $300.00 to $235.00 in a report on Thursday, October 10th. Raymond James increased their price objective on shares of UnitedHealth Group from $265.00 to $300.00 and gave the company a “buy” rating in a report on Friday, July 19th. Finally, ValuEngine raised shares of UnitedHealth Group from a “sell” rating to a “hold” rating in a report on Wednesday, October 2nd. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $283.22.
In other news, Director Richard T. Burke sold 2,000 shares of the firm’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $231.50, for a total value of $463,000.00. Following the transaction, the director now directly owns 187,979 shares of the company’s stock, valued at $43,517,138.50. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Richard T. Burke sold 2,500 shares of the firm’s stock in a transaction dated Thursday, September 19th. The stock was sold at an average price of $233.40, for a total transaction of $583,500.00. Following the completion of the transaction, the director now directly owns 187,979 shares in the company, valued at $43,874,298.60. The disclosure for this sale can be found here. Over the last three months, insiders sold 24,000 shares of company stock worth $5,924,120. Insiders own 0.82% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: Options Trading – What is a Straddle?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.